The Interventional Radiology Division at Mount Sinai has long been considered one of the premier groups for minimally invasive treatment of cancer, specifically liver cancer. Our Division utilizes a full array of technologies to safely and effectively treat cancer. We treat tumors using transarterial catheter based therapies such as chemoembolization, also referred to as TACE, Y90 radioembolization, and bland embolization. We also utilize percutaneous techniques, which encompass radiofrequency ablation, cryoablation, and microwave ablation.
As a leader in the field of interventional oncology, we are also involved with numerous research studies utilizing the latest breakthroughs in treatment therapies. This provides us the opportunity to utilize the most innovative technologies, such as 3D navigational devices, to safely treat your tumor with the minimum amount of radiation exposure.
Comprehensive Care for Liver Cancer
Our multidisciplinary team of experts in the fields of oncology, surgery, liver medicine, and radiation oncology work together to provide the best care to patients. Our Division has considerable experience and expertise in treating liver cancer due to the tremendous volume of interventional oncologic procedures performed on a daily basis. We perform the highest volume of advanced, minimally invasive treatments for cancer in the United States. Our Division’s care for our patients is comprehensive, including a full array of dedicated and compassionate nurses and physician assistants, to help facilitate your admission and post-procedure care.